LTFS
PDSB icon

Ladenburg Thalmann Financial Services’s PDS Biotechnology PDSB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
11
– – ﹤0.01% 5453
2019
Q3 		$0 Hold
11
– – ﹤0.01% 5398
2019
Q2 		$0 Hold
11
– – ﹤0.01% 5365
2019
Q1 		$0 Buy
+11
New +$92 ﹤0.01% 5294
2018
Q1 		– Sell
-13
Closed -$2K – 5171
2017
Q4 		$2K Buy
+13
New +$2.62K ﹤0.01% 4797

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AFM
Andesa Financial Management Allentown, Pennsylvania $195M AUM 2.34% 1-Year Est. Return
RC
RegentAtlantic Capital Morristown, New Jersey $3.34B AUM 14.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PDSB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its PDS Biotechnology (PDSB) position steady in Q4 2019 at 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5453.

Ladenburg Thalmann Financial Services first reported a position in PDSB in Q4 2017 and has held it in 5 quarters since. The position peaked at $2K in Q4 2017. 21 funds tracked by Wall St. Rank hold PDSB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 11 shares of PDS Biotechnology worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its PDS Biotechnology share count unchanged in Q4 2019.
  • PDS Biotechnology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5453 holding.
  • Ladenburg Thalmann Financial Services first reported a position in PDS Biotechnology in Q4 2017 and has held it in 5 quarters since.
  • Ladenburg Thalmann Financial Services's PDS Biotechnology position peaked at $2K in Q4 2017.
  • 21 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.